Article

Carl Zeiss Meditec owns majority interest

Jena, Germany—Carl Zeiss Meditec AG has acquired 87.1% of IOLTech SA, the French ophthalmic surgery specialist Carl Zeiss Meditec has committed to taking over.

Jena, Germany-Carl Zeiss Meditec AG has acquired 87.1% of IOLTech SA, the French ophthalmic surgery specialist Carl Zeiss Meditec has committed to taking over.

The German company had acquired about 63% of the IOLTech shares from its former principal shareholder as of Feb. 1. About two-thirds of the remaining minority shareholders accepted Carl Zeiss Meditec's voluntary public takeover bid by April 5.

"The company considers this result of the takeover bid as a further successful milestone on Carl Zeiss Meditec's way to the complete takeover of IOLTech," Carl Zeiss Meditec announced.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.